These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Drug therapy for amyotrophic lateral sclerosis: Where are we now?
    Author: Carter GT, Krivickas LS, Weydt P, Weiss MD, Miller RG.
    Journal: IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618.
    Abstract:
    In the 60 years since Lou Gehrig died from amyotrophic lateral sclerosis (ALS) there have been numerous advances in our understanding of this disease. However, scant progress has been made regarding disease-altering treatments. Today most physicians still recommend vitamin E, which is the treatment Gehrig himself received. In this paper we will review what is currently known about the pathophysiology of ALS as well as the history of clinical trials in ALS. We indicate current and future directions in research and clinical trials, and also argue that a logical next step for clinical trials in ALS should be combination drug treatment.
    [Abstract] [Full Text] [Related] [New Search]